Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, focusing on misleading statements regarding the company's financial health and ability to manage macroeconomic challenges during a specified class period [1][4]. Company Allegations - The lawsuit claims that Dow overstated its ability to handle macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [4]. - It is alleged that Dow failed to disclose the true extent of negative impacts from competitive pressures, softening global sales, and product oversupply [4]. Financial Performance - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00 due to ongoing weakness in key markets, which led to a stock price drop of over 3% [5]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million [6]. - Following the disappointing results, Dow's stock price fell by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share to maintain financial flexibility [6]. Legal Process - Investors who purchased Dow securities during the class period can seek appointment as lead plaintiff in the lawsuit, which allows them to represent the interests of all class members [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8]. - The firm has a strong track record in obtaining significant recoveries in securities class action cases, including the largest recovery in history at $7.2 billion from the Enron case [9].
DOW INVESTOR NOTICE: Dow Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit